Inmune Bio (INMB) Assets (2017 - 2026)
Inmune Bio (INMB) posted Assets of $25.8 million for Q1 2026, down 20.19% sequentially from $32.4 million in Q4 2025, and down 31.7% YoY from $37.8 million in Q1 2025.
Inmune Bio (INMB) Assets (2017 - 2026) Analysis & Trends
Inmune Bio has reported Assets for 10 years, with the latest figure at $25.8 million in Q1 2026.
- Quarterly Assets fell 31.7% year-over-year to $25.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.8 million (down 31.7% YoY) and the FY2025 annual result came in at $32.4 million, down 18.23% from the prior year.
- Assets fell to $25.8 million in Q1 2026 per INMB's latest filing, from $32.4 million in the prior quarter.
- Over five years, Assets peaked at $94.4 million in Q1 2022 and troughed at $25.8 million in Q1 2026.
- A 5-year average of $58.3 million and a median of $54.9 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets jumped 44.66% in 2022, then tumbled 36.8% in 2025.
- Over 5 years, Assets stood at $81.8 million in 2022, then plunged by 30.31% to $57.0 million in 2023, then sank by 30.59% to $39.6 million in 2024, then decreased by 18.23% to $32.4 million in 2025, then dropped by 20.19% to $25.8 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $25.8 million, $32.4 million, and $33.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 19.82 Bn |
| 10 | Inmune Bio | 62.12 Mn | 43.71 Mn | - | 26.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.85 Mn |
| Mar 31, 2026 | 25.82 Mn |
| Dec 31, 2025 | 32.35 Mn |
| Sep 30, 2025 | 33.36 Mn |
| Mar 31, 2025 | 37.80 Mn |
| Dec 31, 2024 | 39.56 Mn |
| Sep 30, 2024 | 52.78 Mn |
| Jun 30, 2024 | 52.45 Mn |
| Mar 31, 2024 | 46.83 Mn |
| Dec 31, 2023 | 57.00 Mn |
| Sep 30, 2023 | 62.70 Mn |
| Jun 30, 2023 | 69.72 Mn |
| Mar 31, 2023 | 73.98 Mn |
| Dec 31, 2022 | 81.80 Mn |
| Sep 30, 2022 | 83.80 Mn |
| Jun 30, 2022 | 87.81 Mn |
| Mar 31, 2022 | 94.35 Mn |
| Dec 31, 2021 | 99.95 Mn |
| Sep 30, 2021 | 107.67 Mn |
| Jun 30, 2021 | 60.70 Mn |